Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lucero Itzel Torres Valdiviezo"'
Autor:
Monica Isabel Meneses-Medina, Jorge Humberto Hernandez-Felix, Luis Guillermo Anaya-Sánchez, Ana Karen Valenzuela-Vidales, Vanessa Rosas-Camargo, Edgar Omar Martos-Armendariz, Lucero Itzel Torres-Valdiviezo, Alberto Cedro-Tanda, Alejandro Noguez-Ramos, Luis Alonso Herrera-Montalvo, Alfredo Hidalgo-Miranda, Raymundo David Valdez-Echeverria, Arturo Galindo-Fraga, Fidel David Huitzil-Meléndez
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1639-1646 (2021)
PURPOSECancer treatment during the COVID-19 pandemic represents a challenge. Hospital visits to receive treatment and interaction with health care workers (HCW) represent potential contagious events. We aimed to determine SARS-CoV-2 infection rate am
Externí odkaz:
https://doaj.org/article/fce99bb4259a4199b0d4fb6aa11cb602
Autor:
Jorge Humberto Hernandez-Felix, Alejandro Noguez-Ramos, Mauricio Rivera Aguilar, Ana K. Valenzuela-Vidales, Vanessa Rosas-Camargo, Alberto Cedro-Tanda, Lucero Itzel Torres-Valdiviezo, Cesar Rodrigo Arce-Sandoval, Miriam Heidi Cisneros-Cordero, Andrea Luviano, Fidel David Huitzil-Melendez, Monica I. Meneses-Medina
Purpose: After colorectal cancer (CCR) treatment, adequate follow-up is recommended to improve overall survival. We aimed to assess the adherence to the National Comprehensive Cancer Network clinical practice guidelines on post-treatment surveillance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de5487301d4c9ca358c99fed9f274884
https://doi.org/10.21203/rs.3.rs-1537954/v1
https://doi.org/10.21203/rs.3.rs-1537954/v1
Autor:
Cesar Arce Sandoval, Mónica Isabel Meneses Medina, Miriam Heidi Cisneros Cordero, Jorge Humberto Hernandez-Felix, Vanessa Rosas Camargo, Lucero Itzel Torres Valdiviezo, Rixci Ramirez, Jesus Alejandro Gabutti Thomas, Fidel David David Huitzil Melendez
Publikováno v:
Journal of Clinical Oncology. 41:644-644
644 Background: liver metastases (LM) from well-differentiated gastroenteropancreatic neuroendocrine tumors (wd-GEP-NET) can develop in 28-77% of patients (pts) in their lifetime. Multiple treatments can provide radiological and symptomatic response.
Autor:
Mónica Isabel Meneses Medina, Luis Guillermo Anaya Sanchez, Jorge Humberto Hernandez-Felix, Lucero Itzel Torres Valdiviezo, Vanessa Rosas Camargo, Alberto Cedro-Tanda, Luis Federico Uscanga Dominguez, Martin Lajous, Francisco Valdovinos Aldaca, Fagundo Sierra Reynerio, Alejandro Noguez-Ramos, Fidel David Huitzil Melendez
Publikováno v:
Journal of Clinical Oncology. 40:67-67
67 Background: in Mexico, Colorectal Cancer (CRC) is a leading cause of cancer death, yet population-based screening programs are lacking. In our center, a cohort was created to validate a risk calculator to detect advanced colorectal neoplasia, and
Autor:
Lucero Itzel Torres Valdiviezo, Karla Lucero Rodríguez Flores, Vanessa Rosas Rosas Camargo, Alejandro Noguez-Ramos, Mónica Isabel Meneses Medina, Ximena Rosas Flota, Armando Gamboa Dominguez, Fidel David Huitzil Melendez
Publikováno v:
Journal of Clinical Oncology. 40:617-617
617 Background: Ampullary cancer (AC) represents 0.2% of gastrointestinal cancers. Given the rarity of the disease, information regarding treatment strategies and outcomes derives from studies that include the different types of periampullary cancers
Autor:
Arturo Galindo Fraga, Luis Alonso Herrera Montalvo, Ana Karen Valenzuela, Alfredo Hidalgo, Alberto Cedro-Tanda, Fidel David Huitzil Melendez, Lucero Itzel Torres Valdiviezo, Mónica Isabel Meneses Medina, Jorge Humberto Hernandez-Felix, Luis Guillermo Anaya Sánchez, Vanessa Rosas Camargo, Edgar Omar Martos Armendariz
Publikováno v:
Journal of Clinical Oncology. 39:e13518-e13518
e13518 Background: COVID-19 detection in a timely manner in patients (pts) undergoing anticancer treatment is essential. RT-PCR test for SARS-CoV2 is the diagnostic gold standard, however it is a potentially limited resource in our setting. As an alt
Autor:
Edgar Omar Martos Armendariz, Alberto Cedro-Tanda, Lucero Itzel Torres Valdiviezo, Luis Guillermo Anaya Sánchez, Vanessa Rosas Camargo, Luis Alonso Herrera Montalvo, Ana Karen Valenzuela, Jorge Humberto Hernandez-Felix, Mónica Isabel Meneses Medina, Arturo Galindo Fraga, Fidel David Huitzil Melendez, Alfredo Hidalgo
Publikováno v:
Journal of Clinical Oncology. 39:e22521-e22521
e22521 Background: Cancer treatment during the COVID-19 pandemic represents a challenge. Increased hospital visits to receive treatment as well as interaction with healthcare personnel (HCP), represent a potential risk factor for acquiring COVID-19.